Yen Phung

Can Tho University — VN

Medicine · Health Sciences

15h-index1.2kcitations33works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(18), Cancer Research and Treatments(15), Glycosylation and Glycoproteins Research(10), Cancer Cells and Metastasis(5), Toxin Mechanisms and Immunotoxins(5)

Publications33 total

Optimising antidiabetic medication management for type 2 diabetes and renal dysfunction in Can Tho City, Vietnam
Menopausal Review·2024Open Access
Supplementary Methods from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Data from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Data from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Table 2 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Figure 3 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Table 1 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Figure 1 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Figure 3 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Methods from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Table 2 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Figure 2 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Figure 1 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Figure 2 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Supplementary Table 1 from A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface
2023Open Access
Tumour growth in mice resistant to diet-induced obesity
2015· 1 citedOpen Access
New High Affinity Monoclonal Antibodies Recognize Non-Overlapping Epitopes On Mesothelin For Monitoring And Treating Mesothelioma
Scientific Reports·2015· 55 citedOpen Access
Glypican-3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy
Molecular Pharmaceutics·2015· 68 citedOpen Access
Photoimmunotherapy of Hepatocellular Carcinoma-Targeting Glypican-3 Combined with Nanosized Albumin-Bound Paclitaxel
Nanomedicine·2015· 65 citedOpen Access
Cytomegalovirus and Epstein-Barr Virus in Breast Cancer
PLoS ONE·2015· 102 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Mitchell Ho(26), Mingqian Feng(20), Zhewei Tang(15), Weizao Chen(15), Amit Chaudhary(15), Brad St. Croix(15), Dimiter S. Dimitrov(15), Wei Gao(13), Min Qian(12), Wei Gao(6), Heungnam Kim(4), Min Qian(3), Tomas Ganz(2), Elizabeta Nemeth(2), Margaret J. Currie(2), Bridget A. Robinson(2), V. Courtney Broaddus(2), Hirofumi Hanaoka(2), Kazuhide Sato(2), Rira Watanabe(2)